关键词：抗微生物；抗生素药物；加速生长；耐药性菌株
摘 要：Antimicrobial and antibiotic drugs are used to treat various conditions that affect animals such as companion animals, swine, cattle, horses, and fish. These drugs are also used to accelerate the growth of animals, especially in North America and Europe. However, an overuse of antibiotics has led to the development of antibiotic-resistant strains of microorganisms. This is a worrying trend as the resistant microbes could be transferred to humans by the consumption of milk or meat. Hence, organizations such as the CDC in the US and RUMA in the UK recommend judicious use of antibiotics in animals and strictly regulate the market.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Veterinary Drug Approval Process

07. Market Landscape

07.1 Market Overview

07.2 Market Size and Forecast

07.3 Five Forces Analysis

08. Market Segmentation by Chemical

Class

08.1 Tetracyclines

08.2 Penicillins

08.3 Sulfonamides

08.4 Macrolides

08.5 Aminoglycosides

08.6 Cephalosporins

08.7 Others

09. Market Segmentation by Type of

Animal

09.1 Aquatic Animals

09.2 Farm Animals

09.3 Companion Animals

10. Geographical Segmentation

10.1 Global Animal Antimicrobials and Antibiotics

Market by Geographical Segmentation 2014-

2019

10.2 Animal Antimicrobials and Antibiotics Market in

Americas

10.2.1 Market Size and Forecast

10.3 Animal Antimicrobials and Antibiotics Market in

EMEA

10.3.1 Market Size and Forecast

10.3.2 Animal Antimicrobials and Antibiotics Market in APAC

Market Size and Forecast

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

18.1 Competitive Scenario

18.1.1 Key News

18.1.2 Mergers and Acquisitions

18.2 Market Share Analysis 2014

18.2.1 Zoetis

18.2.2 Merck Animal Health

18.2.3 Merial

18.2.4 Elanco

18.2.5 Bayer

18.3 Other Prominent Vendors

19. Key Vendor Analysis

19.1 Bayer

19.1.1 Key facts

19.1.2 Business Overview

19.1.3 Business segmentation by revenue 2014

19.1.4 Business segmentation by revenue 2013 and 2014

19.1.5 Geographical segmentation by revenue 2014

19.1.6 Business strategy

19.1.7 Recent developments

19.1.8 SWOT analysis

19.2 Elanco Animal Health

19.2.1 Key Facts

19.2.2 Business Overview

19.2.3 Business Strategy

19.2.4 Recent Developments

19.2.5 SWOT Analysis

19.3 Merck Animal Health

19.3.1 Key Facts

19.3.2 Business Overview

19.3.3 Business Strategy

19.3.4 Recent Developments

19.3.5 SWOT Analysis

19.4 Merial

19.4.1 Key Facts

19.4.2 Business Overview

19.4.3 Business Strategy

19.4.4 Recent Developments

19.4.5 SWOT Analysis

19.5 Zoetis

19.5.1 Key Facts

19.5.2 Business Overview

19.5.3 Business Segmentation by Revenue 2013

19.5.4 Business Segmentation by Revenue 2012 and 2013

19.5.5 Geographical Segmentation by Revenue 2013

19.5.6 Business Strategy

19.5.7 Recent Developments

19.5.8 SWOT Analysis

20. Other Reports in this Series